140 related articles for article (PubMed ID: 32088124)
1. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
Min W; Hou Z; Zhang F; Xie S; Yuan K; Dong H; Wang L; Qi L; Luo C; Ding H; Yang P
Bioorg Med Chem; 2020 Apr; 28(7):115372. PubMed ID: 32088124
[TBL] [Abstract][Full Text] [Related]
2. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C
J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175
[TBL] [Abstract][Full Text] [Related]
5. Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine.
Hirano T; Fujiwara T; Niwa H; Hirano M; Ohira K; Okazaki Y; Sato S; Umehara T; Maemoto Y; Ito A; Yoshida M; Kagechika H
ChemMedChem; 2018 Aug; 13(15):1530-1540. PubMed ID: 29882380
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Woo J; Kim HY; Byun BJ; Chae CH; Lee JY; Ryu SY; Park WK; Cho H; Choi G
Bioorg Med Chem Lett; 2014 Jun; 24(11):2486-92. PubMed ID: 24767850
[TBL] [Abstract][Full Text] [Related]
7. Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.
Fujiwara T; Ohira K; Urushibara K; Ito A; Yoshida M; Kanai M; Tanatani A; Kagechika H; Hirano T
Bioorg Med Chem; 2016 Sep; 24(18):4318-4323. PubMed ID: 27448773
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
Wang S; Yang H; Su M; Lian F; Cong Z; Wei R; Zhou Y; Li X; Zheng X; Li C; Fu X; Han X; Shi Q; Li C; Zhang N; Geng M; Liu H; Li J; Huang X; Wang J
Eur J Med Chem; 2021 Oct; 222():113592. PubMed ID: 34147909
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines.
Kondengaden SM; Luo LF; Huang K; Zhu M; Zang L; Bataba E; Wang R; Luo C; Wang B; Li KK; Wang PG
Eur J Med Chem; 2016 Oct; 122():382-393. PubMed ID: 27393948
[TBL] [Abstract][Full Text] [Related]
10. Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.
Hamidi T; Singh AK; Veland N; Vemulapalli V; Chen J; Hardikar S; Bao J; Fry CJ; Yang V; Lee KA; Guo A; Arrowsmith CH; Bedford MT; Chen T
J Biol Chem; 2018 Aug; 293(33):12770-12780. PubMed ID: 29959229
[TBL] [Abstract][Full Text] [Related]
11. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
12. SET7/9 interacts and methylates the ribosomal protein, eL42 and regulates protein synthesis.
Mahesh A; Khan MIK; Govindaraju G; Verma M; Awasthi S; Chavali PL; Chavali S; Rajavelu A; Dhayalan A
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118611. PubMed ID: 31751593
[TBL] [Abstract][Full Text] [Related]
13. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
14. Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
Takemoto Y; Ito A; Niwa H; Okamura M; Fujiwara T; Hirano T; Handa N; Umehara T; Sonoda T; Ogawa K; Tariq M; Nishino N; Dan S; Kagechika H; Yamori T; Yokoyama S; Yoshida M
J Med Chem; 2016 Apr; 59(8):3650-60. PubMed ID: 27088648
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of benzimidazole derivatives as the G9a Histone Methyltransferase inhibitors that induce autophagy and apoptosis of breast cancer cells.
Zhang J; Yao D; Jiang Y; Huang J; Yang S; Wang J
Bioorg Chem; 2017 Jun; 72():168-181. PubMed ID: 28460359
[TBL] [Abstract][Full Text] [Related]
16. KMT Set7/9 is a new regulator of Sam68 STAR-protein.
Vasileva E; Shuvalov O; Petukhov A; Fedorova O; Daks A; Nader R; Barlev N
Biochem Biophys Res Commun; 2020 May; 525(4):1018-1024. PubMed ID: 32178870
[TBL] [Abstract][Full Text] [Related]
17. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
Gibbons GS; Chakraborty A; Grigsby SM; Umeano AC; Liao C; Moukha-Chafiq O; Pathak V; Mathew B; Lee YT; Dou Y; Schürer SC; Reynolds RC; Snowden TS; Nikolovska-Coleska Z
Eur J Med Chem; 2020 Mar; 189():112023. PubMed ID: 31978781
[TBL] [Abstract][Full Text] [Related]
18. Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.
Dhorma LP; Teli MK; Nangunuri BG; Venkanna A; Ragam R; Maturi A; Mirzaei A; Vo DK; Maeng HJ; Kim MH
Eur J Med Chem; 2022 Jan; 227():113880. PubMed ID: 34656041
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
[TBL] [Abstract][Full Text] [Related]
20. Structure-Guided Discovery of a Potent and Selective Cell-Active Inhibitor of SETDB1 Tudor Domain.
Guo Y; Mao X; Xiong L; Xia A; You J; Lin G; Wu C; Huang L; Wang Y; Yang S
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8760-8765. PubMed ID: 33511756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
